New incubator biotope launches to support biotech startup teams on their journey to success

The incubator is an initiative by VIB, one of the world’s premier research institutes and the driving force behind the vibrant Flanders life sciences ecosystem.

24 March 2022, Ghent, Belgium

Incubator program biotope by VIB launches today to support biotech startup teams looking to impact people’s lives through innovation. Biotope will help early entrepreneurs to transform their ideas into viable businesses, with an initial focus on agrifood innovation. The incubator is an initiative by VIB, one of the world’s premier research institutes and the driving force behind the vibrant Flanders life sciences ecosystem. Thanks to strategic investment by the Flemish Government, the European Union, the City of Ghent, and VIB, biotope can offer expert mentorship and a high-tech infrastructure to future biotech leaders from around the world. ​ 

Jérôme Van Biervliet, managing director of VIB: “VIB has an internationally recognized track record in building leading biotech companies from the scientific output of VIB. But all good ideas deserve dedicated support, regardless of their origin. With biotope, VIB wishes to provide biotech entrepreneurs with the mentoring, technology, and initial capital they need to grow their ideas into viable businesses. We envisage that biotope will be a catalyst to stimulate entrepreneurship in young talent and will contribute to the acceleration of the Flanders biotech ecosystem.” 
VIB Agro-Incubator greenhouse

Biotope supports startups developing sustainable solutions in the agrifood domain, where innovation is desperately needed to help meet the global challenges of climate change, sustainable agriculture, and healthy food. Flanders is at the very heart of one of the world’s most innovative and active agrifood regions, providing startups with an ideal launchpad to start their journey as a biotope graduate. ​ 

The uniqueness of biotope lies in its personalized approach, and in developing the team, business, and scientific aspects of a startup. The selected teams receive pre-seed funding and intensive mentoring to build their business skills. The scientists can access high-tech facilities (including labs and greenhouses) where they can develop their technology. During the 12-month incubator program, interactions with international experts, biotech executives, research partners, and professional investors will foster their growth and get them ready for private funding. 

biotope managers Tony Montoye and Annick Verween
Annick Verween, biotope manager: “No science-based business journey is ever the same, which is why the core strength of biotope is our carefully engineered tailormade program. We limit the biotope cohorts to a small number of startups, to provide each team with highly dedicated, hands-on support. Our mission is to ensure that new startups take root and grow as part of our accelerating agrifood biotech ecosystem. We’re very excited to announce the launch of our first call for applicants and are grateful to our partners for making this program possible.” 

The first call for applicants is now open to biotech startup teams with convincing, innovative agrifood biotech ideas with a transformative potential. Biotope welcomes both local and international teams originating from either academia or industry. Applications are open until April 30th, with the first cohort to be announced by early July 2022. 

Website preview
biotope supports biotech startups from launch to viable business  | biotope by VIB
biotope by VIB is a preseed incubator program that supports early biotech entrepreneurs with building their start-up.
biotope by VIB
Joran Lauwers

Joran Lauwers

Press Contact, VIB

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be